vaccine immune response

K-pop K-pop stocks surge as China set to loosen cultural ban after 9 years

Shares in South Korea’s leading entertainment companies are rallying amid growing signs that China will likely lift its longstanding ban on Ko...

Economy China says it is aiming to coordinate tariff response with Japan, South Korea

.video-container { position: relative; padding-bottom: 56.25%; padding-top: 30px; height: 0; overflow: hidden; } .video-container ifr...

Pension funds NPS to mull responsible investment system for alternative investments

South Korea’s National Pension Service (NPS), the world’s third-largest pension fund, is poised to consider expanding its responsible in...

Electric vehicles Hyundai, Kia ready to ramp up EV output in Europe, US

South Korea’s top two automakers Hyundai Motor Co. and Kia Corp. are expected to ramp up electric vehicle production in Europe and the US to b...

Bio & Pharma JLK gets OK from FDA for ICH diagnosis solution

South Korea’s JLK Inc., an AI-based diagnosis solution and platform maker, said on Monday it got 501K approval from the US Food and Drug Admin...

Bio & Pharma SK Bioscience, Sanofi to develop next-gen pneumococcal vaccines

South Korea's SK Bioscience Co. said on Friday it signed an expanded agreement with Sanofi to co-develop next-generation pneumococcal conjugate vacc...

Energy Korea bags Romanian project to refurbish nuclear reactor

Korea Hydro & Nuclear Power Co. (KHNP) on Thursday inked a final agreement with Romania’s Societatea Nationala Nuclearelectrica (SNN) to r...

Tech, Media & Telecom Naver, Saudi Arabia's NHC to build JV

South Korea’s Naver Corp. said on Monday it signed a memorandum of understanding (MOU) with Saudi Arabia’s National Housing Company (NHC...

Bio & Pharma SK Bioscience's SKYCellflu approved in Indonesia

SK Bioscience Co., a bio and pharmaceutical affiliate of South Korea's SK Group, said on Wednesday that The Indonesian Food and Drug Authority BPOM ...

Earnings Samsung chip head vows drastic revamp after flagging weak Q3 earnings

Jun Young-hyun, vice chairman and head of Samsung Electronics Co.'s semiconductor business, on Tuesday vowed to take drastic steps to improve profit...

Artificial intelligence 42Maru builds defense-specialized GenAI platform

42Maru, South Korea's generative AI and language AI startup said on Friday that it was selected as the lead organization for the Defense Technolog...

Construction Hyundai opens climate change response edu Center in Vietnam

South Korea's Hyundai Engineering Co. said on Thursday that it has established a climate change response education center in Thanh Hoa Province, Vie...

Korean startups Enormous market ahead for Hopae, S.Korean DID pioneer

To Hopae Inc., a digital identity solution-developing startup native to South Korea, its home market is small. After successfully accommodating more...

Korean startups Asan Nanum Foundation revamps fund management

The Asan Nanum Foundation, a nonprofit foundation set up in 2011 to commemorate the 10th anniversary of Hyundai founder Chung Ju-yung’s death,...

Bio & Pharma SK Bioscience sells stake in US vaccine developer Novavax

SK Bioscience Co., a drug-making arm of South Korea's No. 2 conglomerate SK Group, has sold a stake in Nasdaq-listed vaccine developer Novavax Inc. ...

Banking & Finance Shinhan Financial builds disaster response system

South Korea's Shinhan Financial Group announced on Sunday that it established a disaster response system to provide swift and substantial assistance...

Automobiles LG Elec selected as Volkswagen's top supplier

LG Electronics Inc. was named the top supplier by Germany's Volkswagen Group. According to industry sources on Thursday, LG Electronics received the...

Mergers & Acquisitions SK Bioscience to buy German vaccine maker IDT Biologika for $244 mn

South Korea’s vaccine developer SK Bioscience Co. will acquire a controlling stake in the world’s top 10 vaccine firm IDT Biologika GmbH...

North Korea North Korea Sent Excrement Balloons. South Korea’s Response: Blasting BTS Hits.

SEOUL—After enduring days of balloon bombardment from the Kim Jong Un regime, South Korea countered with an airwaves assault of it...

Bio & Pharma EuBiologics gets WHO certification for cholera vaccine facility

South Korea's EuBiologics Co. announced on Friday that the vaccine bulk production facility at its Chuncheon Plant No. 2 for the oral cholera vacc...

Business & Politics Korean government vows stern response to Tokyo’s pressure on Naver

The South Korean government said on Monday it will resolutely respond to any “unfair” measures by Tokyo against Naver Corp., which is re...

ESG POSCO Future M publishes responsible minerals report

South Korea's POSCO Future M Co. announced on Tuesday that it released a responsible minerals report detailing establishing a sustainable supply cha...

Corporate governance Hanwha Vision joins UNGC

South Korea's Hanwha Vision Co. announced on Monday that it joined the United Nations Global Compact (UNGC), an international initiative for corpora...

Bio & Pharma SK Bioscience exports Sky Cellflu to Thailand

South Korea's SK Bioscience Co. announced on Thursday that it has shipped about 440,000 doses (for single-dose administration) of its cell-cultured ...

Korean chipmakers SK Hynix to build US chip packaging plant in Indiana: FT

SK Hynix Inc., the world’s second-largest memory chip producer, is reported to have picked Indiana as the site for its advanced chip packaging...

Artificial intelligence LG gets global AI management system certification

LG Electronics Inc. announced on Monday that it has received the Artificial Intelligence Management System (ISO/IEC 42001) certification, an interna...

Bio & Pharma SK Bioscience start to deliver Novavax COVID-19 vaccine

South Korea's SK Bioscience Co. announced on Tuesday that it started to deliver the Novavax COVID-19 vaccine against XBB.1.5 variant.According to No...

Bio & Pharma SK Bioscience applies Phase 3 trials in US for pneumococcal vaccine

South Korea's SK Bioscience Co. announced on Monday that it submitted the Investigational New Drug (IND) application for the Phase 3 clinical trial ...

Bio & Pharma Korea to invest $200 mn in new drugs, vaccines by 2028

South Korea’s health ministry will allocate 261.6 billion won ($200.2 million) for two funds over the next four years to boost private sector ...

Bio & Pharma GC Biopharma wins $10 mn order for flu vaccine in Thailand

South Korea's GC Biopharma Corp. announced on Thursday that its flu vaccine GC Flu secured a $10 million order in the upcoming bid by Thailand's Gov...